Investor Relations Roundtable
The T2B Investor Relations Roundtable empowers biopharma communicators to navigate the complex investor landscape and integrate IR seamlessly into broader corporate affairs strategies. Supporting professionals across all levels, the roundtable fosters collaboration and equips members with tools to enhance trust, credibility, and effective communication with the IR community and beyond.
Roundtable objectives
- Facilitate knowledge-sharing to effectively engage investors, analysts, and other key stakeholders amid global market dynamics.
- Develop frameworks for integrating IR into corporate communications, ensuring consistent and cohesive messaging.
- Align evolving corporate affairs priorities with IR considerations spanning crisis communications, critical data readouts, ESG reporting, and expanding investor bases.
- Strengthen T2B’s programming with IR-focused resources and connections that address real-world challenges and opportunities.
About the chair
Ami Bavishi, Former Executive Director, Head of IR and Corporate Communications, Rallybio
Ami is an experienced investor relations professional with 15 years of experience in the industry, both on the agency and corporate (in-house) side. Most recently, Ami was the Executive Director, Head of Investor Relations and Corporate Communications at Rallybio, where she was responsible for overseeing the Company’s investor relations (IR) and communications efforts, including shaping the IR and communications strategies. Prior to joining Rallybio, Ami was the Director of Investor Relations at Aerie Pharmaceuticals Inc., where she oversaw all IR activities. Prior to Aerie, Ami held positions of increasing responsibility at Burns McClellan, a New York-based life science IR and public relations firm, including Vice President of Investor Relations. At Burns, Ami oversaw day-to-day IR and communications activities for multiple public biotechnology companies. Prior to returning to Burns in 2012, Ami worked as a business development professional at U.K. Trade and Investment, the business development arm of the U.K. government, where she sourced and developed bilateral investment and trade in the U.S. and U.K. life science sectors. Ami began her career in IR and communications at Burns in 2007 as an Account Executive.
Ami holds a master’s in public health in Epidemiology from The George Washington
University and a bachelor’s in biology from Duquesne University.
Apply
Applications open in late March 2025. Each member term is for one calendar year.
“I am excited to lead the Investor Relations Roundtable for T2B as the IR role continues to evolve in our industry amidst the ever-changing global markets. I hope that the roundtable will be able to share our collective knowledge and experiences to develop relevant and important IR resources and guides, such as aligning IR with corporate communications, as well as brainstorm how to more effectively engage with the broader Wall Street community.”
